Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 40

Results For "Vice-President"

1005 News Found

Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9
Clinical Trials | March 14, 2024

Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9

Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers


European Commission approves Pfizer’s Prevenar 20 to help protect infants and children against pneumococcal disease
Drug Approval | March 13, 2024

European Commission approves Pfizer’s Prevenar 20 to help protect infants and children against pneumococcal disease

PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally


Solara Active Pharma elevates Arun Kumar Baskaran to the post of CFO
People | March 09, 2024

Solara Active Pharma elevates Arun Kumar Baskaran to the post of CFO

Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function


EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer
Drug Approval | March 07, 2024

EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer

The validations confirm the completion of the applications and commence the scientific review process


Dr. Lal PathLabs CEO Bharath Uppilliappan steps down
People | March 07, 2024

Dr. Lal PathLabs CEO Bharath Uppilliappan steps down

Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO


Amita Sharma redesignated As COO- API at Morepen Lab
People | March 07, 2024

Amita Sharma redesignated As COO- API at Morepen Lab

Sharma joined the Morepen Lab in 2004


Bayer strengthens pharma portfolio with new cardiology drug acoramidis
News | March 06, 2024

Bayer strengthens pharma portfolio with new cardiology drug acoramidis

Acquisition of exclusive commercialization rights for European markets


BlueRock Therapeutics Phase I clinical trial for Parkinson’s disease continues to show positive trends
Clinical Trials | March 06, 2024

BlueRock Therapeutics Phase I clinical trial for Parkinson’s disease continues to show positive trends

Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months


Pfizer Oncology hosts innovation day
News | March 01, 2024

Pfizer Oncology hosts innovation day

Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth


VP Dhankhar emphasizes need for ethical standards in the medical profession at APICON-2024
News | February 24, 2024

VP Dhankhar emphasizes need for ethical standards in the medical profession at APICON-2024

The Vice President also highlighted the importance of preventive healthcare and fitness